Suchergebnisse - "Shi, Fengxia"

PubPharm (3)

1

Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma

enthalten in: Journal for immunotherapy of cancer | 2021

von Liu, Y. | Wang, C. | Li, X. | +10

2

Restoration of CD3+CD56+ cell level improves skin lesions in severe psoriasis : A pilot clinical study of adoptive immunotherapy for patients with psoriasis using autologous cytokine-induced killer cells

enthalten in: Cytotherapy | 2018

von Dai, H. | Zhou, Y. | Tong, C. | +4

3

Low-dose decitabine-based chemoimmunotherapy for patients with refractory advanced solid tumors : a phase I/II report

enthalten in: Journal of immunology research | 2014

von Fan, H. | Lu, X. | Wang, X. | +13

1
[1]